Elsayed, M.M.A.; Okda, T.M.; Atwa, G.M.K.; Omran, G.A.; Abd Elbaky, A.E.; Ramadan, A.E.h.
Design and Optimization of Orally Administered Luteolin Nanoethosomes to Enhance Its Anti-Tumor Activity against Hepatocellular Carcinoma. Pharmaceutics 2021, 13, 648.
https://doi.org/10.3390/pharmaceutics13050648
AMA Style
Elsayed MMA, Okda TM, Atwa GMK, Omran GA, Abd Elbaky AE, Ramadan AEh.
Design and Optimization of Orally Administered Luteolin Nanoethosomes to Enhance Its Anti-Tumor Activity against Hepatocellular Carcinoma. Pharmaceutics. 2021; 13(5):648.
https://doi.org/10.3390/pharmaceutics13050648
Chicago/Turabian Style
Elsayed, Mahmoud M. A., Tarek M. Okda, Gamal M. K. Atwa, Gamal A. Omran, Atef E. Abd Elbaky, and Abd El hakim Ramadan.
2021. "Design and Optimization of Orally Administered Luteolin Nanoethosomes to Enhance Its Anti-Tumor Activity against Hepatocellular Carcinoma" Pharmaceutics 13, no. 5: 648.
https://doi.org/10.3390/pharmaceutics13050648
APA Style
Elsayed, M. M. A., Okda, T. M., Atwa, G. M. K., Omran, G. A., Abd Elbaky, A. E., & Ramadan, A. E. h.
(2021). Design and Optimization of Orally Administered Luteolin Nanoethosomes to Enhance Its Anti-Tumor Activity against Hepatocellular Carcinoma. Pharmaceutics, 13(5), 648.
https://doi.org/10.3390/pharmaceutics13050648